Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Has announcements × Advanced Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 30 Breast Neoplasms 22 Parkinson Disease 4, Autosomal Dominant Lewy Body 15 Multiple Myeloma 13 Neoplasms 12 Leukemia, Myeloid, Acute 12 Leukemia, Lymphocytic, Chronic, B-Cell 9 Carcinoma, Renal Cell 9 Prostatic Neoplasms 8 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Colorectal Neoplasms 8 Melanoma 7 Leukemia 7 Recurrence 6 Lymphoma, Non-Hodgkin 6 Carcinoma, Hepatocellular 6 Carcinoma 6 Small Cell Lung Carcinoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Fallopian Tube Neoplasms 5 Adenocarcinoma 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Purpura, Thrombocytopenic, Idiopathic 4 Myelodysplastic Syndromes 4 Lymphoma, Follicular 4 Lymphoma 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Hemophilia A 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02743494 2025-11-18

CheckMate 577

Bristol-Myers Squibb

Phase 3 Completed

794 enrolled 13 charts 1 FDA

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡